SEC Form 4 · accession 0001209191-15-073545
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul B Cleveland
Director
Period of report
Sep 30, 2015
Accepted (ET)
Oct 2, 2015 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $32.76 | Sep 30, 2015 | A | 17,300 | A | — | Sep 29, 2025 | Common Stock | 17,300 | 17,300 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable at a rate of one-third of the shares underlying the option on the one-year anniversary of August 18, 2015, the vesting commencement date, one-third of the shares underlying the option on the two-year anniversary of the vesting commencement date and one-third of the shares underlying the option on the three-year anniversary of the vesting commencement date, for so long as the recipient of the option provides continuous service to the issuer, such that the total shares underlying the option shall be fully vested on the three-year anniversary of the vesting commencement date.